Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Elton

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Molecular Pharmacology|March 9, 2018
The Novel C-terminal Truncated 90-kDa Isoform of Topoisomerase II<i>α</i> (TOP2<i>α</i>/90) Is a Determinant of Etoposide Resistance in K562 Leukemia Cells via Heterodimerization with the TOP2<i>α</i>/170 IsoformRagu Kanagasabai, Soumendrakrishna Karmahapatra, Corey A Kientz, et al.
Molecular Pharmacology|January 15, 2021
CRISPR/Cas9 Genome Editing of the Human Topoisomerase II<i>α</i> Intron 19 5' Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 CellsVictor A Hernandez, Jessika Carvajal-Moreno, Jonathan L Papa, et al.
Molecular Therapy. Nucleic Acids|April 18, 2013
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung CancerYun Wu, Melissa Crawford, Yicheng Mao, et al.
Molecular Endocrinology (Baltimore, Md.)|February 7, 2001
Human angiotensin II type 1 receptor isoforms encoded by messenger RNA splice variants are functionally distinctM M Martin, B M Willardson, G F Burton, et al.
The Journal of Cell Biology|May 1, 1994
Expression and polarized targeting of a rab3 isoform in epithelial cellsE Weber, G Berta, A Tousson, et al.
The Journal of Biological Chemistry|June 26, 2007
The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 bindingMickey M Martin, Jessica A Buckenberger, Jinmai Jiang, et al.
Circulation Research|January 10, 2009
miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2Dmitry Terentyev, Andriy E Belevych, Radmila Terentyeva, et al.
Molecular Pharmacology|December 15, 2019
hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase II<i>α</i> in Human Leukemia K562 Cells with Acquired Resistance to EtoposideEvan E Kania, Jessika Carvajal-Moreno, Victor A Hernandez, et al.
Cardiovascular Research|April 5, 2011
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiologyYoshinori Nishijima, Arun Sridhar, Ingrid Bonilla, et al.
Toxicology Mechanisms and Methods|March 14, 2012
Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamideRishi B Patel, Sainath R Kotha, Lynn A Sauers, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Molecular Pharmacology|March 9, 2018
The Novel C-terminal Truncated 90-kDa Isoform of Topoisomerase II<i>α</i> (TOP2<i>α</i>/90) Is a Determinant of Etoposide Resistance in K562 Leukemia Cells via Heterodimerization with the TOP2<i>α</i>/170 IsoformRagu Kanagasabai, Soumendrakrishna Karmahapatra, Corey A Kientz, et al.
Molecular Pharmacology|January 15, 2021
CRISPR/Cas9 Genome Editing of the Human Topoisomerase II<i>α</i> Intron 19 5' Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 CellsVictor A Hernandez, Jessika Carvajal-Moreno, Jonathan L Papa, et al.
Molecular Therapy. Nucleic Acids|April 18, 2013
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung CancerYun Wu, Melissa Crawford, Yicheng Mao, et al.
Molecular Endocrinology (Baltimore, Md.)|February 7, 2001
Human angiotensin II type 1 receptor isoforms encoded by messenger RNA splice variants are functionally distinctM M Martin, B M Willardson, G F Burton, et al.
The Journal of Cell Biology|May 1, 1994
Expression and polarized targeting of a rab3 isoform in epithelial cellsE Weber, G Berta, A Tousson, et al.
The Journal of Biological Chemistry|June 26, 2007
The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 bindingMickey M Martin, Jessica A Buckenberger, Jinmai Jiang, et al.
Circulation Research|January 10, 2009
miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2Dmitry Terentyev, Andriy E Belevych, Radmila Terentyeva, et al.
Molecular Pharmacology|December 15, 2019
hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase II<i>α</i> in Human Leukemia K562 Cells with Acquired Resistance to EtoposideEvan E Kania, Jessika Carvajal-Moreno, Victor A Hernandez, et al.
Cardiovascular Research|April 5, 2011
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiologyYoshinori Nishijima, Arun Sridhar, Ingrid Bonilla, et al.
Toxicology Mechanisms and Methods|March 14, 2012
Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamideRishi B Patel, Sainath R Kotha, Lynn A Sauers, et al.
Pageof 12